11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      The TCR is an allosterically regulated macromolecular machinery changing its conformation while working

      1 , 2 , 3 , 4 , 1 , 2 , 3
      Immunological Reviews
      Wiley

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references134

          • Record: found
          • Abstract: not found
          • Article: not found

          On the nature of allosteric transitions: A plausible model

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            How TCRs bind MHCs, peptides, and coreceptors.

            Since the first crystal structure determinations of alphabeta T cell receptors (TCRs) bound to class I MHC-peptide (pMHC) antigens in 1996, a sizable database of 24 class I and class II TCR/pMHC complexes has been accumulated that now defines a substantial degree of structural variability in TCR/pMHC recognition. Recent determination of free and bound gammadelta TCR structures has enabled comparisons of the modes of antigen recognition by alphabeta and gammadelta T cells and antibodies. Crystal structures of TCR accessory (CD4, CD8) and coreceptor molecules (CD3epsilondelta, CD3epsilongamma) have further advanced our structural understanding of most of the components that constitute the TCR signaling complex. Despite all these efforts, the structural basis for MHC restriction and signaling remains elusive as no structural features that define a common binding mode or signaling mechanism have yet been gleaned from the current set of TCR/pMHC complexes. Notwithstanding, the impressive array of self, foreign (microbial), and autoimmune TCR complexes have uncovered the diverse ways in which antigens can be specifically recognized by TCRs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Accumulation of dynamic catch bonds between TCR and agonist peptide-MHC triggers T cell signaling.

              TCR-pMHC interactions initiate adaptive immune responses, but the mechanism of how such interactions under force induce T cell signaling is unclear. We show that force prolongs lifetimes of single TCR-pMHC bonds for agonists (catch bonds) but shortens those for antagonists (slip bonds). Both magnitude and duration of force are important, as the highest Ca(2+) responses were induced by 10 pN via both pMHC catch bonds whose lifetime peaks at this force and anti-TCR slip bonds whose maximum lifetime occurs at 0 pN. High Ca(2+) levels require early and rapid accumulation of bond lifetimes, whereas short-lived bonds that slow early accumulation of lifetimes correspond to low Ca(2+) responses. Our data support a model in which force on the TCR induces signaling events depending on its magnitude, duration, frequency, and timing, such that agonists form catch bonds that trigger the T cell digitally, whereas antagonists form slip bonds that fail to activate.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Immunological Reviews
                Immunol Rev
                Wiley
                0105-2896
                1600-065X
                August 12 2019
                September 2019
                August 12 2019
                September 2019
                : 291
                : 1
                : 8-25
                Affiliations
                [1 ]Department of Immunology, Faculty of Biology Albert‐Ludwigs‐University of Freiburg Freiburg Germany
                [2 ]Signalling Research Centres BIOSS and CIBSS University of Freiburg Freiburg Germany
                [3 ]Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty Freiburg Germany
                [4 ]Centro de Biología Molecular Severo Ochoa CSIC‐UAM Madrid Spain
                Article
                10.1111/imr.12788
                31402501
                44822873-6f3b-4207-a3ce-9ae1b6a533b8
                © 2019

                http://doi.wiley.com/10.1002/tdm_license_1.1

                History

                Comments

                Comment on this article